MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2025.04.007

Медицинская библиотека · American heart journal · 2025

Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial.

Feistritzer Hans-Josef, Jobs Alexander, Zeymer Uwe, Schneider Steffen, Lauten Philipp, Ferenc Miroslaw, Weferling Maren, Brinkmann Regine, Winkler Sebastian, Landmesser Ulf, Trippel Tobias, Stellbrink Christoph, Wienbergen Harm, Fürnau Georg, Möllmann Helge, Linke Axel, Jung Christian, Lauten Alexander, Achenbach Stephan, Rassaf Tienush, Schmitz Thomas, Cremer Sebastian, Olivier Christoph, Schächinger Volker, Sossalla Samuel, Toischer Karl, Templin Christian, Sedding Daniel, Clemmensen Peter, Tigges Eike, Meincke Felix, Sharar Haitham Abu, Kulenthiran Saarraaken, Schulze P Christian, Jacobshagen Claudius, Frank Derk, Baldus Stephan, Lehmann Ralf, Spies Christian, Klein Norbert, Eitel Ingo, Zahn Ralf, Schmeisser Alexander, Gori Tommaso, Lurz Philipp, Akin Ibrahim, Chatzis Georgios, Rizas Konstantinos, Kessler Thorsten, Ademaj Fadil, Elsässer Albrecht, Maier Lars, Öner Alper, Staudt Alexander, Werner Nikos, Geisler Tobias, Keßler Mirjam, Ferrari Markus Wolfgang, Seyfarth Melchior, Nordbeck Peter, Ewen Sebastian, Bietau Christian, Haghikia Arash, Reinstadler Sebastian J, Geppert Alexander, Hösler Nadine, Toth-Gayor Gabor, Billmann Björn, Tschierschke Ramon, Schmidt Christian, Fichtlscherer Stephan, Thiele Holger, COMPLETE-NSTEMI Investigators

Протокол клинического исследованияСтатьяПеревод в очереди

Аннотация

BACKGROUND

Multivessel coronary artery disease (CAD) is present in 30% to 70% of patients presenting with non-ST-segment elevation myocardial infarction (NSTEMI) depending on varying age and risk profiles. In contrast to the STEMI cohort, there is only limited scientific evidence derived from randomized controlled trials directing the general decision for or against complete revascularization in the NSTEMI population.

PRIMARY HYPOTHESIS: The COMPLETE-NSTEMI trial aims to investigate whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with NSTEMI and multivessel CAD.

DESIGN

COMPLETE-NSTEMI is a prospective, randomized, controlled, multicenter, parallel group, open-label trial. It will enroll 3390 NSTEMI patients with multivessel CAD at 65 to 70 sites in Germany and Austria. Patients will be randomized 1:1 to either complete revascularization with PCI or culprit lesion-only PCI.

ENDPOINTS: The primary efficacy endpoint is a composite of cardiovascular death or rehospitalization for nonfatal myocardial infarction during follow-up. The trial is event-driven and will be stopped as soon as 578 primary endpoint events and a minimal follow-up duration of 12 months for each patient are reached.

CURRENT STATUS: The first patient was enrolled at October 27, 2023. By April 2025, 51 sites have been activated and >500 patients have been randomized. Completion of recruitment is expected for the first half of 2027. The final results of the primary endpoint are expected in 2028.

OUTLOOK: COMPLETE NSTEMI will be the first dedicated trial to answer the question about the optimal revascularization strategy in patients with NSTEMI and multivessel CAD.

TRIAL REGISTRATION: CLINICALTRIALS.GOV: NCT05786131.

Для цитирования: Feistritzer Hans-Josef, Jobs Alexander, Zeymer Uwe, Schneider Steffen, Lauten Philipp, Ferenc Miroslaw, Weferling Maren, Brinkmann Regine, Winkler Sebastian, Landmesser Ulf, Trippel Tobias, Stellbrink Christoph, Wienbergen Harm, Fürnau Georg, Möllmann Helge, Linke Axel, Jung Christian, Lauten Alexander, Achenbach Stephan, Rassaf Tienush, Schmitz Thomas, Cremer Sebastian, Olivier Christoph, Schächinger Volker, Sossalla Samuel, Toischer Karl, Templin Christian, Sedding Daniel, Clemmensen Peter, Tigges Eike, Meincke Felix, Sharar Haitham Abu, Kulenthiran Saarraaken, Schulze P Christian, Jacobshagen Claudius, Frank Derk, Baldus Stephan, Lehmann Ralf, Spies Christian, Klein Norbert, Eitel Ingo, Zahn Ralf, Schmeisser Alexander, Gori Tommaso, Lurz Philipp, Akin Ibrahim, Chatzis Georgios, Rizas Konstantinos, Kessler Thorsten, Ademaj Fadil, Elsässer Albrecht, Maier Lars, Öner Alper, Staudt Alexander, Werner Nikos, Geisler Tobias, Keßler Mirjam, Ferrari Markus Wolfgang, Seyfarth Melchior, Nordbeck Peter, Ewen Sebastian, Bietau Christian, Haghikia Arash, Reinstadler Sebastian J, Geppert Alexander, Hösler Nadine, Toth-Gayor Gabor, Billmann Björn, Tschierschke Ramon, Schmidt Christian, Fichtlscherer Stephan, Thiele Holger, COMPLETE-NSTEMI Investigators. Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial.. American heart journal. 2025. DOI: 10.1016/j.ahj.2025.04.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.